HSA Product

DBL POTASSIUM ACETATE CONCENTRATED INJECTION 2.45 g/5 ml

Product approved by Health Sciences Authority (SG)

Basic Information

Product Name

DBL POTASSIUM ACETATE CONCENTRATED INJECTION 2.45 g/5 ml

Dosage Form

INJECTION

Regulatory Information

Approval Number

SIN05868P

Approval Date

May 21, 1991

Forensic Classification

General Sale List

Drug Type

Therapeutic

Route of Administration

INTRAVENOUS

Record Created

August 10, 2023

Last Updated

May 30, 2025

ATC Business ID

XB05XA17

Company Information

ManufacturerSiegfried Hameln GmbH

Registrant

PFIZER PRIVATE LIMITED

Licence Holder

PFIZER PRIVATE LIMITED

Active Ingredients

POTASSIUM ACETATE (ANHYDROUS)

Strength: 2.45 g/5 ml

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy